Feb. 2026

Fuent (Qurgen’s China subsidiary) has expanded its cell-conversion cancer therapy in the following five additional clinical sites:

• Shandong Cancer Hospital;
• The First Hospital of Lanzhou University;
• Beijing Go Broad Hospital;
• Sun Yat-sen University Cancer Center;
• The First Affiliated Hospital of Xi’an Jiaotong University.